午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
Always be check!!!These tablets are the most dangerous
 
Author:中國銘鉉 企劃部  Release Time:2017-8-24 11:24:22  Number Browse:847
 
Chinese medicine is one of the four national quintessence of China, which supports the development of Chinese medicine for thousands of years.TCM treatment emphasizes the balance of Yin and Yang.The theory of yin-yang equilibrium can be traced to the shang dynasty (1600-1100bc).

However, in recent years, the quality and safety of Chinese medicinal materials have been repeatedly issued, which is not only a warning to the development of traditional Chinese medicine, but also seriously endangers the health and safety of the people.

▍ yinpian unqualified: jaw-dropping

Take traditional Chinese medicine as an example, its quality is unqualified quantity of quantity, let a person stare at a tongue.

Food drug administration in fujian province after the third phase of drug sampling 2016 issued by the quality announcement, Chinese medicine yinpian accounted for the proportion of large rejected product is as high as 88.23%, the proportion of the proportion with the recently released by the other provinces sampling rejected product ratio.

Specific varieties and unqualified items are as follows:



Professor of Chinese pharmaceutical university has pointed out that the processing and processing of traditional Chinese medicine has long been short of precise specifications, and the arbitrariness of the processing operation is likely to lead to the loss of effective components.

Dichroa root can be medicine, for example, but the quality of a material is hard, not easy to soften, the traditional processing method is to use the "lip", namely in the medicine and water, but not too much at a time, need to be repeated several times, ensure it is not lost medicine effective component, quality is guaranteed.And now a lot of processing method is too simple, be "bubble", a bubble is half month, the effect is lost.

Yunnan baiyao's most important raw materials wild weight building, also known as seven leaves of a flower, has been endangered.

More of the crude herbs are found in old and poor areas, and growers use various means to increase production.For example, the production of hormone pesticides is doubled, but whether the effect is still the same is still to be investigated.

Due to the particularity of Chinese medicinal materials, many medicinal herbs are processed in a similar way when they are processed.So, for convenience, many herbs in origin directly processed into slices specifications, origin is unified management and standard requirements, has been the farmer tradition and oneself fumble, no unified standards and strict monitoring

Although the bad medicine is bad, even harmful, but the market does not have a problem - what kind of price can provide what kind of goods, its essence is to fake to be true, shoddy.The waste materials of agricultural and sideline products and the non-medical parts of the medicinal herbs are bought by some medicinal herbs for a low price and eventually circulated to the market.

▍ these varieties are often "listed"

Through the sampling statistics, the author analyzed that there are many varieties of Chinese medicinal materials not qualified to be qualified: the dragon, the red flower, the white peony, the saponiae, the cattail, the firewood, the dodder, the aloes, the white skin, the yam.

The dragon is the earthworm.The dragon is an important Chinese herbal medicine.

Earthworms are included in 67 animal medicines collected in the shennonga book.The dragon has the effect of clearing, clearing, clearing, breathing and diuresis.It is often used in high fever, daze, convulsive convulsion, joint pain, lung heat and cough, urinary dropsy, hypertension, etc.It is also used in thrombolytic and anticoagulation, cardiovascular system, nervous system, and cancer treatment.

The reasons for the quality of the dragon are not in conformity with heavy metal and total ash.

In May 2017, the food and drug administration of jiangsu province exposed the quality of the production of diron in hebei chufeng Chinese medicine co., LTD., batch number B505221.In 2016, in weifang fangzi district, renkang hospital was notified of the sale of substandard ground dragons, and its production enterprise was bozhou city of luxury Chinese medicine yinpian co., LTD., the production batch number was 141201.Eat food safety in the interactive minority autonomous county in qinghai province in 2017 (a) sampling, found a batch lumbricus (slices) was found to be of poor quality, production unit of anhui people's Chinese medicine yinpian co., LTD., unqualified project for the total ash content does not conform to the standard, the batch number 160801.

The number of unqualified products is:

Inflammation can be better piece, ageratum water/liquid/gas/capsule, tablet on the effect, rhizoma coptidis, soft capsule, : rhinitis, three porn, bezoar detoxify, jianwei xiaoshi tablets, vitamin C, fructus forsythiae, liuwei dihuang capsule, rheumatoid arthritis, essential balm.

Inflammation can be better for the health care, and over-the-counter medicines, used for acute tonsillitis, bacterial pneumonia, acute conjunctivitis, otitis media, furuncle sore 癗 Li, acute mastitis, enteritis, bacterial dysentery and acute urinary tract infections and other diseases.

On January 26, 2017, national food drug administration released 14 batches of drug unqualified notice in yanbian, jilin ao pharmaceutical co., LTD. Production of inflammation can board the HeiBang ning tablets, batch number is 1502001;On July 11, 2016, pingxiang food and drug inspection office checked out the quality of the diphonitis tablets produced by jilin aodong yanbian pharmaceutical co., LTD., and the batch number was 1407001.The reasons for the non-conformance of inflammation in the jilin aodong include: the detection of dahuang glycoside, the difference of weight difference.

The water of the zhengqi is the god medicine, its medicine manual says can be dematerized wet, rational qi and medium.It is used for the cold, internal injury, wet stagnation or the cold of summer injury, and the symptoms can be found in the headache, the chest diaphragm, the abdominal distention, the vomiting and diarrhea.It also applies to the gastrointestinal cold.

The author found that seven companies producing the largest number of ageratum upright drugs is unqualified, respectively is brilliant pharmaceutical co., LTD., jilin province, sichuan province prosperous hayashido pharmaceutical co., LTD., hunan mawangdui pharmaceutical co., LTD., xinhui pharmaceutical co., LTD., jilin province, jilin province sea-crossing biochemical pharmaceutical manufacturing co., LTD., guizhou anshun west pharmaceutical co., LTD., jilin province, and overseas Chinese pharmaceutical co., LTD.

▍ should increase the penalties

The quality problems of Chinese medicine companies have been repeatedly caused because the punishment is too light.This causes enterprises to pay less attention to the quality of the products, and the industry of medicine is especially serious, and if it is punished in a row, it will be fined.

Recently, the state food and drug administration joined a number of departments to jointly regulate the production of substandard products. It was only fined, and now it is subject to a judicial investigation.China's food and drug administration has adopted a more rigorous review mechanism, and has repeatedly flown inspections.

Chinese medicine companies should not only be concerned with economic interests, but should not be lucky.Traditional Chinese medicine is the quintessence of Chinese medicine, and it is necessary for colleagues to strictly follow GMP production and protect Chinese national essence.In this way, the Chinese medicine can go to the world and the future.
 
Previous article:The market of large scale restriction of infusion antibiotics in China will be challenged
Next article:Alishatan, a Chinese new class of new drugs, is trying to stir up the 80 billion hypertensive market
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網安備 44011202000029號